aibioMXCT MAXCYTE, INC.
MAXCYTE, INC. (MXCT) news
MAXCYTE, INC. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker MXCT, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest MAXCYTE, INC. news
We have not published a story on MAXCYTE, INC. yet. When there is news, it will appear here.
MAXCYTE, INC. annual financials
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $33.0 million | $38.6 million |
| Research and development | $20.8 million | $22.2 million |
| Net income (loss) | -$44.6 million | -$41.1 million |
| Cash from operations | -$34.4 million | -$27.6 million |
| Cash and equivalents | $20.1 million | $27.9 million |
| Short-term investments | $83.0 million | $126.6 million |
Questions about MAXCYTE, INC.
What is the ticker symbol of MAXCYTE, INC.?
MAXCYTE, INC. trades under the ticker MXCT on NASDAQ.
Where is MAXCYTE, INC. listed?
MAXCYTE, INC. is listed on NASDAQ.
Which country or territory is MAXCYTE, INC. listed under?
Our directory records MAXCYTE, INC. under United States.
Does aibio.space cover MAXCYTE, INC.?
aibio.space lists MAXCYTE, INC. among 2,820 public biotech companies and publishes its news here as stories appear.
What was MAXCYTE, INC.'s revenue last year?
$33.0 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.
Is MAXCYTE, INC. profitable?
MAXCYTE, INC. reported a net loss of $44.6 million for the fiscal year ended Dec 31, 2025, and used $34.4 million of cash in operations, per its annual report to the SEC.
How much does MAXCYTE, INC. spend on research and development?
$20.8 million in the fiscal year ended Dec 31, 2025, per its annual report.
How much cash does MAXCYTE, INC. have?
$105.7 million in cash and short-term investments at Jun 30, 2026, per its 10-Q.
Investor discussion: MAXCYTE, INC.
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
- Listings
Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01). Source
Stock chart
Listing details
- Company
- MAXCYTE, INC.
- Ticker
- MXCT
- Listing
- NASDAQ
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction